Skip to main content Skip to footer

INTIENT Unify Cell & Gene

Enabling next-gen therapies

Advancing Cell & Gene therapies

Advancing Cell & Gene Therapies: Dr. Khalid Shah

Industry leads on Advancing Cell & Gene Therapies


Harmonized, efficient 

Enabling streamlined interactions between healthcare providers and manufacturers, reducing administrative burden, cost, and improving time-to-therapy.

Compliant, secure

GxP and HIPAA compliant, safeguarding the privacy of patient data and manufacturer intellectual property.

Configurable, modular

Configurable for clinical and commercial therapies and modalities. Modular deployment supports developers at different stages in their CGT lifecycle.


Our leaders

Beth Hayes

Cell and Gene Therapy Product Lead

Anthony Romito

Managing Director – Life Sciences, INTIENT and Patient Services, Global

Sanjay Srivastava, Ph.D

Managing Director – Life Sciences, Cell and Gene Lead

Frequently asked questions